Blue Note Therapeutics is a prescription digital therapeutics company singularly dedicated to helping patients live better. Blue Note is merging deep scientific and clinical expertise with digital and gaming ideas to transform care for seriously ill patients. Working closely with leading medical researchers and patient advocacy organizations, Blue Note is creating clinically validated, FDA-approvable, and prescription-only digital devices to treat the burden of illness. The company was founded in 2018 and is based in San Francisco, California.

Early identification of at-risk patient groups for treatment non-adherence

Improved workflow efficiency and increased patient load

Automated RPM data sync & analysis

Actionable insights for patient segments

EHR integration

Cancer-related distress, which can be defined as any unpleasant feeling, emotion, or experience that affects a cancer patient’s quality of life or ability to cope with cancer diagnosis and treatment, affects millions of people. Fewer than half of those who experience cancer-related distress have access to the mental health care they need to find relief. Blue Note Therapeutics is working to close this gap.

New technologies, devices and therapeutics have brought great benefits to people with chronic conditions. But remote health can only be effective when patients, alone 24/7, comply with their treatment programs.